Terumo Health Outcomes Now Offers FDA-Cleared Medis QFR® 3.0 Software for Coronary Physiology Assessment in the US

Terumo Health Outcomes Now Offers FDA-Cleared Medis QFR® 3.0 Software for Coronary Physiology Assessment in the US

– Innovative AI software supports hospital adoption of advanced tools to improve cath lab workflow and patient comfort –

Terumo brings Medis QFR 3.0 to US market - Cardiovascular News

Terumo Health Outcomes (THO), a division of Terumo Interventional Systems (TIS), has announced that Medis QFR 3.0, a US Food and Drug Administration (FDA)-cleared software solution for coronary physiology assessment, is now available in the USA through its collaboration with Medis Medical Imaging. “Helping hospitals access proven, innovative tools like QFR 3.0 is an important part of our mission,” said Ryan Graver, senior divisional vice preside…